Author

Corrine Quirk

Rockefeller UniversityORCID 0009-0002-4235-7158Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2 Genomics· 1 Molecular Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Assay:CRISPR screen· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Charles M. RiceiD· 5 shared Antonis AthanasiadisiD· 4 shared Catherine A. FreijeiD· 4 shared Chenhui Zou· 4 shared Eleftherios MichailidisiD· 4 shared Georgios DangasiD· 4 shared Leon Louis SeifertiD· 4 shared Yichen ZhouiD· 4 shared

Activity by Year

2026-2026 · peak 5/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

Charles M. RiceORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 8, 2026

Genetic accessibility, not superior fitness, determines which anti-HBs antibody escape variants are selected in patients

Yingpu Yu, Eleftherios Michailidis, Leon Louis Seifert…·Ype P. de Jong

This study identifies that genetic accessibility, not superior fitness, determines the selection of anti-HBs antibody escape variants in patients using in vivo screening.

DOI 10.64898/2026.10.06.756817

humanexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintSep 23, 2026

The HBV basal core promoter mutation confers a replicative advantage and transcriptionally reprograms hepatocytes toward HCC subtypes

Leon Louis Seifert, Georgios Dangas, Hoyin Chu…·Ype P. de Jong

This study shows that HBV BCP mutations enhance viral replication and alter hepatocyte transcription, linking to specific HCC subtypes.

DOI 10.64898/2026.09.22.752323

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintAug 18, 2026

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors

Ansgar F. Stenzel, Antonis Athanasiadis, Georgios Dangas…·Eleftherios Michailidis

The paper develops CRISPR-Cas9 delivery methods for primary human hepatocytes to enable efficient gene editing and screening of HBV host factors.

DOI 10.64898/2026.08.10.743996

humanCRISPR screen

𝕏 PostBluesky

MicrobiologybioRxivPreprintJul 24, 2026

Orthogonal CRISPR screens and human liver chimeric mice identify hepatitis B virus host factors

Catherine A. Freije, Georgios Dangas, Antonis Athanasiadis…·Eleftherios Michailidis

The paper identifies HBV host factors using CRISPR screens and human liver chimeric mice, finding that EXOC1 is antiviral and ZCCHC14 is proviral.

DOI 10.64898/2026.07.23.740386

humangenetic perturbation / CRISPR

𝕏 PostBluesky

PathologyJournal of HepatologyPeer-reviewedMar 11, 2026

An immunocompetent murine model of virus-elicited liver fibrosis and hepatocellular carcinoma

Mariana Nogueira Batista, Juliano Bordignon, Ana Luiza Pamplona Mosimann…·Charles M. Rice

This study develops an immunocompetent mouse model of virus-induced liver fibrosis and hepatocellular carcinoma using Norway rat hepacivirus.

2 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky